Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4)

Sang Yun Lee; Hyeong Jun Cho; Jimin Choi; Bosung Ku; Seok Whan Moon; Mi Hyoung Moon; Kyung Soo Kim; Kwanyong Hyun; Tae Jung Kim; Yeoun Eun Sung; Yongki Hwang; Eunyoung Lee; Dong Hyuck Ahn; Joon Young Choi; Jeong Uk Lim; Chan Kwon Park; Sung Won Kim; Seung Joon Kim; In Seong Koo; Woo Seok Jung; Sang Hyun Lee; Chang Dong Yeo; Dong Woo Lee

doi:10.1186/s13046-023-02919-3

Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4)

Sang Yun Lee, Hyeong Jun Cho, Jimin Choi, Bosung Ku, Seok Whan Moon, Mi Hyoung Moon, Kyung Soo Kim, Kwanyong Hyun, Tae Jung Kim, Yeoun Eun Sung, Yongki Hwang, Eunyoung Lee, Dong Hyuck Ahn, Joon Young Choi, Jeong Uk Lim, Chan Kwon Park, Sung Won Kim, Seung Joon Kim, In Seong Koo, Woo Seok JungSang Hyun Lee, Chang Dong Yeo, Dong Woo Lee

Research output: Contribution to journal › Comment/debate

Abstract

Following publication of the original article [1], authors would like to correct the Funding section of their article. The sentence currently reads: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2019M3A9H2032425). This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2020R1I1A306655012). This work was supported by the Ministry of Science and ICT, (Project Number: (2022) ERIC07_1_1) and Commercialization Promotion Agency for R&D Outcomes (COMPA). The sentence should read: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2019M3A9H2032425). This research was supported by the Commercialization Promotion Agency for R&D Outcomes(COMPA) funded by the Ministry of Science and ICT(MSIT) (project number: RS_2023-00259649, No. 1,711,196,063).This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT; the Ministry of Trade, Industry and Energy; the Ministry of Health & Welfare; and the Ministry of Food and Drug Safety) (project number: RS_2023-00255627). The correction does not affect the overall result or conclusion of the article. The original article has been corrected.

Original language	English
Article number	332
Journal	Journal of Experimental and Clinical Cancer Research
Volume	42
Issue number	1
DOIs	https://doi.org/10.1186/s13046-023-02919-3
State	Published - Dec 2023

Bibliographical note

Publisher Copyright:
© 2023, The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13046-023-02919-3

Fingerprint

Dive into the research topics of 'Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4)'. Together they form a unique fingerprint.

Cite this

Lee, S. Y., Cho, H. J., Choi, J., Ku, B., Moon, S. W., Moon, M. H., Kim, K. S., Hyun, K., Kim, T. J., Sung, Y. E., Hwang, Y., Lee, E., Ahn, D. H., Choi, J. Y., Lim, J. U., Park, C. K., Kim, S. W., Kim, S. J., Koo, I. S., ... Lee, D. W. (2023). Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4). Journal of Experimental and Clinical Cancer Research, 42(1), Article 332. https://doi.org/10.1186/s13046-023-02919-3

Lee, Sang Yun ; Cho, Hyeong Jun ; Choi, Jimin et al. / Correction : Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4). In: Journal of Experimental and Clinical Cancer Research. 2023 ; Vol. 42, No. 1.

@article{2cd614dbe12647e9a48ede0206484bcc,

title = "Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4)",

abstract = "Following publication of the original article [1], authors would like to correct the Funding section of their article. The sentence currently reads: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2019M3A9H2032425). This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2020R1I1A306655012). This work was supported by the Ministry of Science and ICT, (Project Number: (2022) ERIC07_1_1) and Commercialization Promotion Agency for R&D Outcomes (COMPA). The sentence should read: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2019M3A9H2032425). This research was supported by the Commercialization Promotion Agency for R&D Outcomes(COMPA) funded by the Ministry of Science and ICT(MSIT) (project number: RS_2023-00259649, No. 1,711,196,063).This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT; the Ministry of Trade, Industry and Energy; the Ministry of Health & Welfare; and the Ministry of Food and Drug Safety) (project number: RS_2023-00255627). The correction does not affect the overall result or conclusion of the article. The original article has been corrected.",

author = "Lee, {Sang Yun} and Cho, {Hyeong Jun} and Jimin Choi and Bosung Ku and Moon, {Seok Whan} and Moon, {Mi Hyoung} and Kim, {Kyung Soo} and Kwanyong Hyun and Kim, {Tae Jung} and Sung, {Yeoun Eun} and Yongki Hwang and Eunyoung Lee and Ahn, {Dong Hyuck} and Choi, {Joon Young} and Lim, {Jeong Uk} and Park, {Chan Kwon} and Kim, {Sung Won} and Kim, {Seung Joon} and Koo, {In Seong} and Jung, {Woo Seok} and Lee, {Sang Hyun} and Yeo, {Chang Dong} and Lee, {Dong Woo}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1186/s13046-023-02919-3",

language = "English",

volume = "42",

journal = "Journal of Experimental and Clinical Cancer Research",

issn = "0392-9078",

publisher = "BioMed Central Ltd.",

number = "1",

}

Lee, SY, Cho, HJ, Choi, J, Ku, B, Moon, SW, Moon, MH, Kim, KS, Hyun, K, Kim, TJ, Sung, YE, Hwang, Y, Lee, E, Ahn, DH, Choi, JY , Lim, JU, Park, CK, Kim, SW , Kim, SJ, Koo, IS, Jung, WS, Lee, SH, Yeo, CD & Lee, DW 2023, 'Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4)', Journal of Experimental and Clinical Cancer Research, vol. 42, no. 1, 332. https://doi.org/10.1186/s13046-023-02919-3

Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4). / Lee, Sang Yun; Cho, Hyeong Jun; Choi, Jimin et al.
In: Journal of Experimental and Clinical Cancer Research, Vol. 42, No. 1, 332, 12.2023.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4)

AU - Lee, Sang Yun

AU - Cho, Hyeong Jun

AU - Choi, Jimin

AU - Ku, Bosung

AU - Moon, Seok Whan

AU - Moon, Mi Hyoung

AU - Kim, Kyung Soo

AU - Hyun, Kwanyong

AU - Kim, Tae Jung

AU - Sung, Yeoun Eun

AU - Hwang, Yongki

AU - Lee, Eunyoung

AU - Ahn, Dong Hyuck

AU - Choi, Joon Young

AU - Lim, Jeong Uk

AU - Park, Chan Kwon

AU - Kim, Sung Won

AU - Kim, Seung Joon

AU - Koo, In Seong

AU - Jung, Woo Seok

AU - Lee, Sang Hyun

AU - Yeo, Chang Dong

AU - Lee, Dong Woo

PY - 2023/12

Y1 - 2023/12

N2 - Following publication of the original article [1], authors would like to correct the Funding section of their article. The sentence currently reads: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2019M3A9H2032425). This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2020R1I1A306655012). This work was supported by the Ministry of Science and ICT, (Project Number: (2022) ERIC07_1_1) and Commercialization Promotion Agency for R&D Outcomes (COMPA). The sentence should read: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2019M3A9H2032425). This research was supported by the Commercialization Promotion Agency for R&D Outcomes(COMPA) funded by the Ministry of Science and ICT(MSIT) (project number: RS_2023-00259649, No. 1,711,196,063).This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT; the Ministry of Trade, Industry and Energy; the Ministry of Health & Welfare; and the Ministry of Food and Drug Safety) (project number: RS_2023-00255627). The correction does not affect the overall result or conclusion of the article. The original article has been corrected.

AB - Following publication of the original article [1], authors would like to correct the Funding section of their article. The sentence currently reads: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2019M3A9H2032425). This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2020R1I1A306655012). This work was supported by the Ministry of Science and ICT, (Project Number: (2022) ERIC07_1_1) and Commercialization Promotion Agency for R&D Outcomes (COMPA). The sentence should read: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2019M3A9H2032425). This research was supported by the Commercialization Promotion Agency for R&D Outcomes(COMPA) funded by the Ministry of Science and ICT(MSIT) (project number: RS_2023-00259649, No. 1,711,196,063).This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT; the Ministry of Trade, Industry and Energy; the Ministry of Health & Welfare; and the Ministry of Food and Drug Safety) (project number: RS_2023-00255627). The correction does not affect the overall result or conclusion of the article. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85178465351&partnerID=8YFLogxK

U2 - 10.1186/s13046-023-02919-3

DO - 10.1186/s13046-023-02919-3

M3 - Comment/debate

C2 - 38057916

AN - SCOPUS:85178465351

SN - 0392-9078

VL - 42

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

IS - 1

M1 - 332

ER -

Lee SY, Cho HJ, Choi J, Ku B, Moon SW, Moon MH et al. Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4). Journal of Experimental and Clinical Cancer Research. 2023 Dec;42(1):332. doi: 10.1186/s13046-023-02919-3

Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC) (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (309), 10.1186/s13046-023-02899-4)

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this